These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 27816963)

  • 1. Defective ciliogenesis in thyroid hürthle cell tumors is associated with increased autophagy.
    Lee J; Yi S; Kang YE; Chang JY; Kim JT; Sul HJ; Kim JO; Kim JM; Kim J; Porcelli AM; Kim KS; Shong M
    Oncotarget; 2016 Nov; 7(48):79117-79130. PubMed ID: 27816963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of primary cilia promotes mitochondria-dependent apoptosis in thyroid cancer.
    Lee J; Park KC; Sul HJ; Hong HJ; Kim KH; Kero J; Shong M
    Sci Rep; 2021 Feb; 11(1):4181. PubMed ID: 33602982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of papillary thyroid carcinoma-associated molecular markers and their significance in follicular epithelial dysplasia with papillary thyroid carcinoma-like nuclear alterations in Hashimoto's thyroiditis.
    Ma H; Yan J; Zhang C; Qin S; Qin L; Liu L; Wang X; Li N
    Int J Clin Exp Pathol; 2014; 7(11):7999-8007. PubMed ID: 25550843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Primary Cilia Results in the Development of Cancer in the Murine Thyroid Gland.
    Lee J; Yi S; Chang JY; Kim JT; Sul HJ; Park KC; Zhu X; Cheng SY; Kero J; Kim J; Shong M
    Mol Cells; 2019 Feb; 42(2):113-122. PubMed ID: 30622229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of Parkin-mediated mitophagy in thyroid Hürthle cell tumors.
    Lee J; Ham S; Lee MH; Kim SJ; Park JH; Lee SE; Chang JY; Joung KH; Kim TY; Kim JM; Sul HJ; Kweon GR; Jo YS; Kim KS; Shong YK; Gasparre G; Chung JK; Porcelli AM; Shong M
    Carcinogenesis; 2015 Nov; 36(11):1407-18. PubMed ID: 26354775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions.
    Chiappetta G; Toti P; Cetta F; Giuliano A; Pentimalli F; Amendola I; Lazzi S; Monaco M; Mazzuchelli L; Tosi P; Santoro M; Fusco A
    J Clin Endocrinol Metab; 2002 Jan; 87(1):364-9. PubMed ID: 11788677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncocytic variant of papillary thyroid carcinoma associated with Hashimoto's thyroiditis: a case report and review of the literature.
    Lee J; Hasteh F
    Diagn Cytopathol; 2009 Aug; 37(8):600-6. PubMed ID: 19526577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced HBME-1 immunoreactivity of papillary thyroid carcinoma and papillary thyroid carcinoma-related neoplastic lesions with Hürthle cell and/or apocrine-like changes.
    Mai KT; Bokhary R; Yazdi HM; Thomas J; Commons AS
    Histopathology; 2002 Feb; 40(2):133-42. PubMed ID: 11952857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
    Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas.
    Nascimento MC; Bisi H; Alves VA; Longatto-Filho A; Kanamura CT; Medeiros-Neto G
    Endocr Pathol; 2001; 12(3):275-9. PubMed ID: 11740048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of CK19 and CD56 in the differentiation of thyroid papillary carcinoma from its mimics.
    Abouhashem NS; Talaat SM
    Pathol Res Pract; 2017 May; 213(5):509-517. PubMed ID: 28214214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of p27(kip1) is associated with cyclin D3 overexpression in the oxyphilic (Hurthle cell) variant of follicular thyroid carcinoma.
    Troncone G; Iaccarino A; Russo M; Palmieri EA; Volante M; Papotti M; Viglietto G; Palombini L
    J Clin Pathol; 2007 Apr; 60(4):377-81. PubMed ID: 16798934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.
    Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B
    Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncocytic nodular hyperplasia of the thyroid.
    Suster D; Ronen N; Giorgadze T
    Ann Diagn Pathol; 2022 Dec; 61():152049. PubMed ID: 36162158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.
    Covach A; Patel S; Hardin H; Lloyd RV
    Endocr Pathol; 2017 Sep; 28(3):207-212. PubMed ID: 28660408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHL1 expression differentiates Hürthle cell carcinoma from benign Hürthle cell nodules.
    Li W; Xia S; Aronova A; Min IM; Verma A; Scognamiglio T; Gray KD; Ullmann TM; Liang H; Moore MD; Elemento O; Zarnegar R; Fahey TJ
    J Surg Oncol; 2018 Nov; 118(6):1042-1049. PubMed ID: 30311656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
    Máximo V; Soares P; Lima J; Cameselle-Teijeiro J; Sobrinho-Simões M
    Am J Pathol; 2002 May; 160(5):1857-65. PubMed ID: 12000737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine-needle aspirations of papillary carcinoma with oncocytic features: an expanded cytologic and histologic profile.
    Renshaw AA
    Cancer Cytopathol; 2011 Aug; 119(4):247-53. PubMed ID: 21400667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC.
    Prasad ML; Huang Y; Pellegata NS; de la Chapelle A; Kloos RT
    Histopathology; 2004 Jul; 45(1):39-46. PubMed ID: 15228442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.